Parents of children with Rett syndrome are able to detect disease-specific differences in the sounds made by babies who…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
More than a quarter of men at large may carry mutations causing Rett syndrome in a portion of their…
The Phase 1/2 REVEAL study, which is testing the investigational gene therapy TSHA-102 in women with Rett syndrome, is expected…
Daybue (trofinetide) is now available in the U.S. to treat Rett syndrome in patients 2 and older, according…
Girls and women with Rett syndrome who participated in a three-month, at-home physical therapy program with occasional remote supervision…
Acadia Pharmaceuticals’ trofinetide has become the first treatment to be approved by the U.S. Food…
Mice with Rett syndrome show abnormalities in their brain circuitry that helps to control movement, which may contribute to…
Analyzing babies’ vocalizations using machine learning could aid in the earlier diagnosis of Rett syndrome, a small study illustrates.
The U.S. Food and Drug Administration (FDA) has set an action date of March 12, 2023 to decide whether or…
Levels of a small RNA molecule called miR-101a may be elevated in certain brain regions of people with Rett…